Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obeticholic Acid for Lipodystrophy Patients
NCT02430077Phase 2Completed
- Start
- Jun 2016
- Primary completion
- Oct 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of obeticholic acid in hepatic steatosis. Started Jun 2016; status: completed.
02
Drugs
obeticholic acid
03
Conditions
hepatic steatosis
Beyond the preview
Go deeper on NCT02430077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02430077.